SCHEDULE: Universe Pharmaceuticals: Stakeholder Reports Ownership Threshold

A significant stakeholder, Whitmore Limited and its controller Chengming Tang, has reported beneficial ownership of 9.97% of Universe Pharmaceuticals' Class A ordinary shares.

Summary

• Whitmore Limited, a company wholly owned and controlled by Chengming Tang, now beneficially owns 499,424 Class A ordinary shares of Universe Pharmaceuticals INC.
• This ownership stake represents 9.97% of the total outstanding Class A ordinary shares.
• The filing is a Schedule 13G, indicating a passive investment stake.
• The total number of outstanding Class A ordinary shares as of July 27, 2026, was 5,008,313.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership that has reached a reportable threshold. There are no significant financial performance indicators or strategic shifts detailed.

Positives

• The filing clearly delineates a significant ownership stake, providing transparency to the market.
• The reporting entities are identified, along with their respective citizenship and addresses.

Negatives

• The filing does not provide any financial performance data or operational updates for Universe Pharmaceuticals INC.
• No strategic initiatives or future plans for the company are disclosed within this document.

Risks

• While this filing itself does not present direct risks, any significant change in beneficial ownership could potentially precede future strategic actions by the reporting persons that may impact the company.
• The concentration of 9.97% ownership in the hands of a single reporting entity could influence corporate governance decisions.

Future Outlook

This filing is a disclosure of ownership and does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

• "The amount in rows 6, 8 and 9 represents 499,424 Class A ordinary shares held by Whitmore Limited, a company with limited liability formed in the British Virgin Islands. Whitmore Limited is wholly owned and controlled by Chengming Tang, an individual."
• "Percentage of class is calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual shareholders accumulating stakes in publicly traded companies. This filing indicates a passive investment approach by Whitmore Limited and Chengming Tang, rather than an attempt to gain control.

Stakeholder Impact

• Shareholders: Increased transparency regarding significant ownership stakes, which could influence market perception and trading activity.
• Management: Awareness of a substantial shareholder whose investment is approaching a level that may warrant engagement or consideration in strategic planning.

Next Steps

• The reporting persons are required to file amendments to this Schedule 13G if any material changes occur in their beneficial ownership.
• The company, Universe Pharmaceuticals INC, may need to monitor the actions of this significant shareholder.

Key Dates

Keywords

beneficial ownership, Schedule 13G, ordinary shares, stakeholder, ownership threshold, Universe Pharmaceuticals